nodes	percent_of_prediction	percent_of_DWPC	metapath
Amoxapine—HRH4—stomach cancer	0.54	0.776	CbGaD
Amoxapine—HTR1A—stomach cancer	0.156	0.224	CbGaD
Amoxapine—HTR3A—myenteric nerve plexus—stomach cancer	0.0097	0.12	CbGeAlD
Amoxapine—HTR3A—vagus nerve—stomach cancer	0.00647	0.08	CbGeAlD
Amoxapine—HTR7—myenteric nerve plexus—stomach cancer	0.00628	0.0776	CbGeAlD
Amoxapine—ORM1—bile—stomach cancer	0.00602	0.0744	CbGeAlD
Amoxapine—HTR7—vagus nerve—stomach cancer	0.00419	0.0517	CbGeAlD
Amoxapine—HTR7—vein—stomach cancer	0.00404	0.05	CbGeAlD
Amoxapine—HTR2A—myenteric nerve plexus—stomach cancer	0.00391	0.0484	CbGeAlD
Amoxapine—HRH4—hematopoietic system—stomach cancer	0.0032	0.0396	CbGeAlD
Amoxapine—HTR2A—vagus nerve—stomach cancer	0.00261	0.0323	CbGeAlD
Amoxapine—HTR2A—vein—stomach cancer	0.00252	0.0312	CbGeAlD
Amoxapine—HRH4—bone marrow—stomach cancer	0.00205	0.0254	CbGeAlD
Amoxapine—ORM1—gall bladder—stomach cancer	0.00167	0.0206	CbGeAlD
Amoxapine—HTR1B—blood vessel—stomach cancer	0.00166	0.0206	CbGeAlD
Amoxapine—HTR7—blood vessel—stomach cancer	0.00128	0.0159	CbGeAlD
Amoxapine—HTR3A—hematopoietic system—stomach cancer	0.00106	0.0131	CbGeAlD
Amoxapine—ORM1—hematopoietic system—stomach cancer	0.000945	0.0117	CbGeAlD
Amoxapine—SLC6A3—hematopoietic system—stomach cancer	0.000879	0.0109	CbGeAlD
Amoxapine—Olanzapine—HRH4—stomach cancer	0.00082	0.196	CrCbGaD
Amoxapine—SLC6A4—hematopoietic system—stomach cancer	0.000805	0.00996	CbGeAlD
Amoxapine—HTR2A—blood vessel—stomach cancer	0.0008	0.00989	CbGeAlD
Amoxapine—HTR3A—digestive system—stomach cancer	0.000735	0.00908	CbGeAlD
Amoxapine—HTR1A—hematopoietic system—stomach cancer	0.000715	0.00884	CbGeAlD
Amoxapine—HTR2B—smooth muscle tissue—stomach cancer	0.000703	0.00869	CbGeAlD
Amoxapine—HTR7—hematopoietic system—stomach cancer	0.000683	0.00845	CbGeAlD
Amoxapine—ADRA1A—hematopoietic system—stomach cancer	0.000659	0.00815	CbGeAlD
Amoxapine—HTR7—epithelium—stomach cancer	0.000625	0.00772	CbGeAlD
Amoxapine—ORM1—bone marrow—stomach cancer	0.000606	0.00749	CbGeAlD
Amoxapine—ADRA1A—epithelium—stomach cancer	0.000603	0.00745	CbGeAlD
Amoxapine—HTR7—smooth muscle tissue—stomach cancer	0.000602	0.00744	CbGeAlD
Amoxapine—SLC6A4—digestive system—stomach cancer	0.00056	0.00692	CbGeAlD
Amoxapine—HTR2B—digestive system—stomach cancer	0.000555	0.00686	CbGeAlD
Amoxapine—ORM1—endocrine gland—stomach cancer	0.000543	0.00671	CbGeAlD
Amoxapine—HRH1—hematopoietic system—stomach cancer	0.00051	0.00631	CbGeAlD
Amoxapine—Loxapine—HRH4—stomach cancer	0.00051	0.122	CrCbGaD
Amoxapine—HTR1B—endocrine gland—stomach cancer	0.000509	0.00629	CbGeAlD
Amoxapine—ADRA2A—hematopoietic system—stomach cancer	0.000501	0.0062	CbGeAlD
Amoxapine—ORM1—liver—stomach cancer	0.00049	0.00605	CbGeAlD
Amoxapine—Asenapine—ADRB1—stomach cancer	0.000476	0.114	CrCbGaD
Amoxapine—HTR7—digestive system—stomach cancer	0.000475	0.00588	CbGeAlD
Amoxapine—HRH1—epithelium—stomach cancer	0.000466	0.00577	CbGeAlD
Amoxapine—ADRA1A—lymphoid tissue—stomach cancer	0.000464	0.00574	CbGeAlD
Amoxapine—SLC6A4—endocrine gland—stomach cancer	0.000463	0.00572	CbGeAlD
Amoxapine—CHRM1—endocrine gland—stomach cancer	0.000461	0.0057	CbGeAlD
Amoxapine—HRH1—smooth muscle tissue—stomach cancer	0.000449	0.00556	CbGeAlD
Amoxapine—Clozapine—HRH4—stomach cancer	0.000428	0.102	CrCbGaD
Amoxapine—Asenapine—HTR1A—stomach cancer	0.000426	0.102	CrCbGaD
Amoxapine—HTR2A—hematopoietic system—stomach cancer	0.000426	0.00527	CbGeAlD
Amoxapine—HTR1A—endocrine gland—stomach cancer	0.000411	0.00508	CbGeAlD
Amoxapine—ADRA2A—pancreas—stomach cancer	0.000408	0.00505	CbGeAlD
Amoxapine—SLC6A2—endocrine gland—stomach cancer	0.000407	0.00504	CbGeAlD
Amoxapine—Asenapine—ADRB2—stomach cancer	0.000401	0.0958	CrCbGaD
Amoxapine—HTR7—endocrine gland—stomach cancer	0.000393	0.00485	CbGeAlD
Amoxapine—HTR2A—epithelium—stomach cancer	0.00039	0.00482	CbGeAlD
Amoxapine—CYP2D6—hematopoietic system—stomach cancer	0.000388	0.0048	CbGeAlD
Amoxapine—ADRA1A—endocrine gland—stomach cancer	0.000379	0.00468	CbGeAlD
Amoxapine—ORM1—lymph node—stomach cancer	0.000375	0.00464	CbGeAlD
Amoxapine—HTR2A—smooth muscle tissue—stomach cancer	0.000375	0.00464	CbGeAlD
Amoxapine—DRD2—endocrine gland—stomach cancer	0.000371	0.00459	CbGeAlD
Amoxapine—HRH1—digestive system—stomach cancer	0.000355	0.00439	CbGeAlD
Amoxapine—HTR7—liver—stomach cancer	0.000354	0.00438	CbGeAlD
Amoxapine—ADRA1A—liver—stomach cancer	0.000342	0.00422	CbGeAlD
Amoxapine—HTR2B—lymph node—stomach cancer	0.000317	0.00392	CbGeAlD
Amoxapine—HTR2A—digestive system—stomach cancer	0.000296	0.00366	CbGeAlD
Amoxapine—HRH1—endocrine gland—stomach cancer	0.000293	0.00362	CbGeAlD
Amoxapine—ADRA2A—endocrine gland—stomach cancer	0.000288	0.00356	CbGeAlD
Amoxapine—SLC6A2—lymph node—stomach cancer	0.000282	0.00348	CbGeAlD
Amoxapine—CYP2D6—digestive system—stomach cancer	0.00027	0.00334	CbGeAlD
Amoxapine—HTR2A—endocrine gland—stomach cancer	0.000245	0.00303	CbGeAlD
Amoxapine—Olanzapine—HTR1A—stomach cancer	0.000237	0.0567	CrCbGaD
Amoxapine—CYP2D6—endocrine gland—stomach cancer	0.000223	0.00276	CbGeAlD
Amoxapine—HTR2A—liver—stomach cancer	0.000221	0.00273	CbGeAlD
Amoxapine—Tinnitus—Capecitabine—stomach cancer	0.000213	0.00191	CcSEcCtD
Amoxapine—Decreased appetite—Irinotecan—stomach cancer	0.000211	0.00189	CcSEcCtD
Amoxapine—Eosinophilia—Methotrexate—stomach cancer	0.000211	0.00189	CcSEcCtD
Amoxapine—Insomnia—Fluorouracil—stomach cancer	0.00021	0.00189	CcSEcCtD
Amoxapine—Fatigue—Irinotecan—stomach cancer	0.000209	0.00188	CcSEcCtD
Amoxapine—Paraesthesia—Fluorouracil—stomach cancer	0.000209	0.00187	CcSEcCtD
Amoxapine—Alopecia—Docetaxel—stomach cancer	0.000209	0.00187	CcSEcCtD
Amoxapine—Pancreatitis—Methotrexate—stomach cancer	0.000209	0.00187	CcSEcCtD
Amoxapine—Constipation—Irinotecan—stomach cancer	0.000208	0.00186	CcSEcCtD
Amoxapine—Somnolence—Fluorouracil—stomach cancer	0.000207	0.00186	CcSEcCtD
Amoxapine—Dyspepsia—Fluorouracil—stomach cancer	0.000205	0.00184	CcSEcCtD
Amoxapine—HRH1—lymph node—stomach cancer	0.000203	0.00251	CbGeAlD
Amoxapine—Decreased appetite—Fluorouracil—stomach cancer	0.000202	0.00181	CcSEcCtD
Amoxapine—Alopecia—Capecitabine—stomach cancer	0.000202	0.00181	CcSEcCtD
Amoxapine—Dysgeusia—Docetaxel—stomach cancer	0.000201	0.00181	CcSEcCtD
Amoxapine—CYP2D6—liver—stomach cancer	0.000201	0.00249	CbGeAlD
Amoxapine—Ataxia—Doxorubicin—stomach cancer	0.0002	0.0018	CcSEcCtD
Amoxapine—Feeling abnormal—Irinotecan—stomach cancer	0.0002	0.0018	CcSEcCtD
Amoxapine—ADRA2A—lymph node—stomach cancer	0.000199	0.00246	CbGeAlD
Amoxapine—Gastrointestinal pain—Irinotecan—stomach cancer	0.000199	0.00178	CcSEcCtD
Amoxapine—Eosinophilia—Epirubicin—stomach cancer	0.000197	0.00177	CcSEcCtD
Amoxapine—Flatulence—Capecitabine—stomach cancer	0.000196	0.00176	CcSEcCtD
Amoxapine—Erectile dysfunction—Methotrexate—stomach cancer	0.000196	0.00176	CcSEcCtD
Amoxapine—Pancreatitis—Epirubicin—stomach cancer	0.000195	0.00175	CcSEcCtD
Amoxapine—Dysgeusia—Capecitabine—stomach cancer	0.000195	0.00175	CcSEcCtD
Amoxapine—Body temperature increased—Irinotecan—stomach cancer	0.000192	0.00172	CcSEcCtD
Amoxapine—Abdominal pain—Irinotecan—stomach cancer	0.000192	0.00172	CcSEcCtD
Amoxapine—Feeling abnormal—Fluorouracil—stomach cancer	0.000192	0.00172	CcSEcCtD
Amoxapine—Drowsiness—Methotrexate—stomach cancer	0.00019	0.0017	CcSEcCtD
Amoxapine—Vision blurred—Capecitabine—stomach cancer	0.000188	0.00168	CcSEcCtD
Amoxapine—Tremor—Capecitabine—stomach cancer	0.000187	0.00167	CcSEcCtD
Amoxapine—Stomatitis—Methotrexate—stomach cancer	0.000185	0.00166	CcSEcCtD
Amoxapine—Urticaria—Fluorouracil—stomach cancer	0.000185	0.00166	CcSEcCtD
Amoxapine—Syncope—Docetaxel—stomach cancer	0.000184	0.00166	CcSEcCtD
Amoxapine—Leukopenia—Docetaxel—stomach cancer	0.000184	0.00165	CcSEcCtD
Amoxapine—Pollakiuria—Epirubicin—stomach cancer	0.000184	0.00165	CcSEcCtD
Amoxapine—Body temperature increased—Fluorouracil—stomach cancer	0.000184	0.00165	CcSEcCtD
Amoxapine—Eosinophilia—Doxorubicin—stomach cancer	0.000182	0.00164	CcSEcCtD
Amoxapine—Palpitations—Docetaxel—stomach cancer	0.000182	0.00163	CcSEcCtD
Amoxapine—Weight increased—Epirubicin—stomach cancer	0.000181	0.00163	CcSEcCtD
Amoxapine—Loss of consciousness—Docetaxel—stomach cancer	0.000181	0.00162	CcSEcCtD
Amoxapine—Pancreatitis—Doxorubicin—stomach cancer	0.000181	0.00162	CcSEcCtD
Amoxapine—Syncope—Capecitabine—stomach cancer	0.000179	0.0016	CcSEcCtD
Amoxapine—Leukopenia—Capecitabine—stomach cancer	0.000178	0.0016	CcSEcCtD
Amoxapine—Convulsion—Docetaxel—stomach cancer	0.000178	0.0016	CcSEcCtD
Amoxapine—Hypertension—Docetaxel—stomach cancer	0.000178	0.00159	CcSEcCtD
Amoxapine—Drowsiness—Epirubicin—stomach cancer	0.000178	0.00159	CcSEcCtD
Amoxapine—Agranulocytosis—Methotrexate—stomach cancer	0.000177	0.00159	CcSEcCtD
Amoxapine—Palpitations—Capecitabine—stomach cancer	0.000176	0.00158	CcSEcCtD
Amoxapine—Loss of consciousness—Capecitabine—stomach cancer	0.000175	0.00157	CcSEcCtD
Amoxapine—Asthenia—Irinotecan—stomach cancer	0.000174	0.00156	CcSEcCtD
Amoxapine—Jaundice—Epirubicin—stomach cancer	0.000173	0.00155	CcSEcCtD
Amoxapine—Stomatitis—Epirubicin—stomach cancer	0.000173	0.00155	CcSEcCtD
Amoxapine—Hypertension—Capecitabine—stomach cancer	0.000172	0.00154	CcSEcCtD
Amoxapine—Dry mouth—Docetaxel—stomach cancer	0.000171	0.00154	CcSEcCtD
Amoxapine—Hepatitis—Methotrexate—stomach cancer	0.00017	0.00153	CcSEcCtD
Amoxapine—Pollakiuria—Doxorubicin—stomach cancer	0.00017	0.00153	CcSEcCtD
Amoxapine—Confusional state—Docetaxel—stomach cancer	0.000169	0.00152	CcSEcCtD
Amoxapine—Oedema—Docetaxel—stomach cancer	0.000168	0.00151	CcSEcCtD
Amoxapine—Weight increased—Doxorubicin—stomach cancer	0.000168	0.0015	CcSEcCtD
Amoxapine—Diarrhoea—Irinotecan—stomach cancer	0.000166	0.00149	CcSEcCtD
Amoxapine—Dry mouth—Capecitabine—stomach cancer	0.000166	0.00149	CcSEcCtD
Amoxapine—Agranulocytosis—Epirubicin—stomach cancer	0.000166	0.00149	CcSEcCtD
Amoxapine—Shock—Docetaxel—stomach cancer	0.000165	0.00148	CcSEcCtD
Amoxapine—Loxapine—ADRB1—stomach cancer	0.000165	0.0394	CrCbGaD
Amoxapine—Pruritus—Fluorouracil—stomach cancer	0.000165	0.00148	CcSEcCtD
Amoxapine—Thrombocytopenia—Docetaxel—stomach cancer	0.000164	0.00148	CcSEcCtD
Amoxapine—Drowsiness—Doxorubicin—stomach cancer	0.000164	0.00147	CcSEcCtD
Amoxapine—Confusional state—Capecitabine—stomach cancer	0.000164	0.00147	CcSEcCtD
Amoxapine—Tachycardia—Docetaxel—stomach cancer	0.000164	0.00147	CcSEcCtD
Amoxapine—Oedema—Capecitabine—stomach cancer	0.000163	0.00146	CcSEcCtD
Amoxapine—Dizziness—Irinotecan—stomach cancer	0.000161	0.00144	CcSEcCtD
Amoxapine—Jaundice—Doxorubicin—stomach cancer	0.00016	0.00144	CcSEcCtD
Amoxapine—Stomatitis—Doxorubicin—stomach cancer	0.00016	0.00144	CcSEcCtD
Amoxapine—Anorexia—Docetaxel—stomach cancer	0.00016	0.00144	CcSEcCtD
Amoxapine—Shock—Capecitabine—stomach cancer	0.00016	0.00144	CcSEcCtD
Amoxapine—Hepatitis—Epirubicin—stomach cancer	0.000159	0.00143	CcSEcCtD
Amoxapine—Diarrhoea—Fluorouracil—stomach cancer	0.000159	0.00143	CcSEcCtD
Amoxapine—Thrombocytopenia—Capecitabine—stomach cancer	0.000159	0.00143	CcSEcCtD
Amoxapine—Tinnitus—Methotrexate—stomach cancer	0.000159	0.00142	CcSEcCtD
Amoxapine—Tachycardia—Capecitabine—stomach cancer	0.000159	0.00142	CcSEcCtD
Amoxapine—Hypoaesthesia—Epirubicin—stomach cancer	0.000159	0.00142	CcSEcCtD
Amoxapine—Hypotension—Docetaxel—stomach cancer	0.000157	0.00141	CcSEcCtD
Amoxapine—Anorexia—Capecitabine—stomach cancer	0.000155	0.00139	CcSEcCtD
Amoxapine—Vomiting—Irinotecan—stomach cancer	0.000154	0.00139	CcSEcCtD
Amoxapine—Dizziness—Fluorouracil—stomach cancer	0.000154	0.00138	CcSEcCtD
Amoxapine—Agranulocytosis—Doxorubicin—stomach cancer	0.000153	0.00138	CcSEcCtD
Amoxapine—Rash—Irinotecan—stomach cancer	0.000153	0.00137	CcSEcCtD
Amoxapine—Dermatitis—Irinotecan—stomach cancer	0.000153	0.00137	CcSEcCtD
Amoxapine—Headache—Irinotecan—stomach cancer	0.000152	0.00137	CcSEcCtD
Amoxapine—Hypotension—Capecitabine—stomach cancer	0.000152	0.00136	CcSEcCtD
Amoxapine—Insomnia—Docetaxel—stomach cancer	0.000152	0.00136	CcSEcCtD
Amoxapine—Paraesthesia—Docetaxel—stomach cancer	0.000151	0.00135	CcSEcCtD
Amoxapine—Alopecia—Methotrexate—stomach cancer	0.00015	0.00135	CcSEcCtD
Amoxapine—Somnolence—Docetaxel—stomach cancer	0.000149	0.00134	CcSEcCtD
Amoxapine—Tinnitus—Epirubicin—stomach cancer	0.000149	0.00133	CcSEcCtD
Amoxapine—Vomiting—Fluorouracil—stomach cancer	0.000148	0.00133	CcSEcCtD
Amoxapine—Dyspepsia—Docetaxel—stomach cancer	0.000148	0.00133	CcSEcCtD
Amoxapine—Hepatitis—Doxorubicin—stomach cancer	0.000147	0.00132	CcSEcCtD
Amoxapine—Loxapine—HTR1A—stomach cancer	0.000147	0.0352	CrCbGaD
Amoxapine—Insomnia—Capecitabine—stomach cancer	0.000147	0.00132	CcSEcCtD
Amoxapine—Hypoaesthesia—Doxorubicin—stomach cancer	0.000147	0.00132	CcSEcCtD
Amoxapine—Rash—Fluorouracil—stomach cancer	0.000147	0.00132	CcSEcCtD
Amoxapine—Dermatitis—Fluorouracil—stomach cancer	0.000147	0.00131	CcSEcCtD
Amoxapine—Paraesthesia—Capecitabine—stomach cancer	0.000146	0.00131	CcSEcCtD
Amoxapine—Decreased appetite—Docetaxel—stomach cancer	0.000146	0.00131	CcSEcCtD
Amoxapine—Headache—Fluorouracil—stomach cancer	0.000146	0.00131	CcSEcCtD
Amoxapine—Dysgeusia—Methotrexate—stomach cancer	0.000145	0.0013	CcSEcCtD
Amoxapine—Fatigue—Docetaxel—stomach cancer	0.000145	0.0013	CcSEcCtD
Amoxapine—Nausea—Irinotecan—stomach cancer	0.000144	0.00129	CcSEcCtD
Amoxapine—Quetiapine—HTR1A—stomach cancer	0.000144	0.0344	CrCbGaD
Amoxapine—Constipation—Docetaxel—stomach cancer	0.000144	0.00129	CcSEcCtD
Amoxapine—Dyspepsia—Capecitabine—stomach cancer	0.000143	0.00128	CcSEcCtD
Amoxapine—Clozapine—CYP2A6—stomach cancer	0.000142	0.034	CrCbGaD
Amoxapine—Decreased appetite—Capecitabine—stomach cancer	0.000141	0.00127	CcSEcCtD
Amoxapine—Alopecia—Epirubicin—stomach cancer	0.000141	0.00126	CcSEcCtD
Amoxapine—Fatigue—Capecitabine—stomach cancer	0.00014	0.00126	CcSEcCtD
Amoxapine—Vision blurred—Methotrexate—stomach cancer	0.00014	0.00125	CcSEcCtD
Amoxapine—Constipation—Capecitabine—stomach cancer	0.000139	0.00125	CcSEcCtD
Amoxapine—Feeling abnormal—Docetaxel—stomach cancer	0.000138	0.00124	CcSEcCtD
Amoxapine—Nausea—Fluorouracil—stomach cancer	0.000138	0.00124	CcSEcCtD
Amoxapine—Tinnitus—Doxorubicin—stomach cancer	0.000137	0.00123	CcSEcCtD
Amoxapine—Gastrointestinal pain—Docetaxel—stomach cancer	0.000137	0.00123	CcSEcCtD
Amoxapine—Flatulence—Epirubicin—stomach cancer	0.000137	0.00123	CcSEcCtD
Amoxapine—Tension—Epirubicin—stomach cancer	0.000136	0.00122	CcSEcCtD
Amoxapine—Dysgeusia—Epirubicin—stomach cancer	0.000136	0.00122	CcSEcCtD
Amoxapine—Nervousness—Epirubicin—stomach cancer	0.000135	0.00121	CcSEcCtD
Amoxapine—Feeling abnormal—Capecitabine—stomach cancer	0.000134	0.0012	CcSEcCtD
Amoxapine—Gastrointestinal pain—Capecitabine—stomach cancer	0.000133	0.00119	CcSEcCtD
Amoxapine—Body temperature increased—Docetaxel—stomach cancer	0.000133	0.00119	CcSEcCtD
Amoxapine—Abdominal pain—Docetaxel—stomach cancer	0.000133	0.00119	CcSEcCtD
Amoxapine—Leukopenia—Methotrexate—stomach cancer	0.000133	0.00119	CcSEcCtD
Amoxapine—Vision blurred—Epirubicin—stomach cancer	0.000131	0.00117	CcSEcCtD
Amoxapine—Alopecia—Doxorubicin—stomach cancer	0.00013	0.00117	CcSEcCtD
Amoxapine—Urticaria—Capecitabine—stomach cancer	0.000129	0.00116	CcSEcCtD
Amoxapine—Abdominal pain—Capecitabine—stomach cancer	0.000128	0.00115	CcSEcCtD
Amoxapine—Body temperature increased—Capecitabine—stomach cancer	0.000128	0.00115	CcSEcCtD
Amoxapine—Convulsion—Methotrexate—stomach cancer	0.000128	0.00115	CcSEcCtD
Amoxapine—Agitation—Epirubicin—stomach cancer	0.000127	0.00114	CcSEcCtD
Amoxapine—Flatulence—Doxorubicin—stomach cancer	0.000126	0.00114	CcSEcCtD
Amoxapine—Tension—Doxorubicin—stomach cancer	0.000126	0.00113	CcSEcCtD
Amoxapine—Dysgeusia—Doxorubicin—stomach cancer	0.000126	0.00113	CcSEcCtD
Amoxapine—Nervousness—Doxorubicin—stomach cancer	0.000125	0.00112	CcSEcCtD
Amoxapine—Syncope—Epirubicin—stomach cancer	0.000124	0.00112	CcSEcCtD
Amoxapine—Leukopenia—Epirubicin—stomach cancer	0.000124	0.00111	CcSEcCtD
Amoxapine—Clozapine—HTR1A—stomach cancer	0.000124	0.0296	CrCbGaD
Amoxapine—Palpitations—Epirubicin—stomach cancer	0.000123	0.0011	CcSEcCtD
Amoxapine—Confusional state—Methotrexate—stomach cancer	0.000122	0.00109	CcSEcCtD
Amoxapine—Loss of consciousness—Epirubicin—stomach cancer	0.000122	0.00109	CcSEcCtD
Amoxapine—Vision blurred—Doxorubicin—stomach cancer	0.000121	0.00109	CcSEcCtD
Amoxapine—Asthenia—Docetaxel—stomach cancer	0.00012	0.00108	CcSEcCtD
Amoxapine—Convulsion—Epirubicin—stomach cancer	0.00012	0.00108	CcSEcCtD
Amoxapine—Hypertension—Epirubicin—stomach cancer	0.00012	0.00107	CcSEcCtD
Amoxapine—Pruritus—Docetaxel—stomach cancer	0.000119	0.00107	CcSEcCtD
Amoxapine—Thrombocytopenia—Methotrexate—stomach cancer	0.000118	0.00106	CcSEcCtD
Amoxapine—Agitation—Doxorubicin—stomach cancer	0.000118	0.00106	CcSEcCtD
Amoxapine—Asthenia—Capecitabine—stomach cancer	0.000117	0.00105	CcSEcCtD
Amoxapine—Dry mouth—Epirubicin—stomach cancer	0.000116	0.00104	CcSEcCtD
Amoxapine—Anorexia—Methotrexate—stomach cancer	0.000115	0.00104	CcSEcCtD
Amoxapine—Syncope—Doxorubicin—stomach cancer	0.000115	0.00103	CcSEcCtD
Amoxapine—Pruritus—Capecitabine—stomach cancer	0.000115	0.00103	CcSEcCtD
Amoxapine—Leukopenia—Doxorubicin—stomach cancer	0.000115	0.00103	CcSEcCtD
Amoxapine—Diarrhoea—Docetaxel—stomach cancer	0.000115	0.00103	CcSEcCtD
Amoxapine—Confusional state—Epirubicin—stomach cancer	0.000114	0.00102	CcSEcCtD
Amoxapine—Palpitations—Doxorubicin—stomach cancer	0.000113	0.00102	CcSEcCtD
Amoxapine—Oedema—Epirubicin—stomach cancer	0.000113	0.00102	CcSEcCtD
Amoxapine—Hypotension—Methotrexate—stomach cancer	0.000113	0.00101	CcSEcCtD
Amoxapine—Loss of consciousness—Doxorubicin—stomach cancer	0.000113	0.00101	CcSEcCtD
Amoxapine—Shock—Epirubicin—stomach cancer	0.000111	0.001	CcSEcCtD
Amoxapine—Convulsion—Doxorubicin—stomach cancer	0.000111	0.000998	CcSEcCtD
Amoxapine—Diarrhoea—Capecitabine—stomach cancer	0.000111	0.000998	CcSEcCtD
Amoxapine—Dizziness—Docetaxel—stomach cancer	0.000111	0.000996	CcSEcCtD
Amoxapine—Thrombocytopenia—Epirubicin—stomach cancer	0.000111	0.000995	CcSEcCtD
Amoxapine—Hypertension—Doxorubicin—stomach cancer	0.000111	0.000995	CcSEcCtD
Amoxapine—Tachycardia—Epirubicin—stomach cancer	0.000111	0.000992	CcSEcCtD
Amoxapine—Insomnia—Methotrexate—stomach cancer	0.000109	0.000982	CcSEcCtD
Amoxapine—Paraesthesia—Methotrexate—stomach cancer	0.000109	0.000975	CcSEcCtD
Amoxapine—Anorexia—Epirubicin—stomach cancer	0.000108	0.000969	CcSEcCtD
Amoxapine—Somnolence—Methotrexate—stomach cancer	0.000108	0.000965	CcSEcCtD
Amoxapine—Dizziness—Capecitabine—stomach cancer	0.000107	0.000965	CcSEcCtD
Amoxapine—Dry mouth—Doxorubicin—stomach cancer	0.000107	0.000959	CcSEcCtD
Amoxapine—Vomiting—Docetaxel—stomach cancer	0.000107	0.000958	CcSEcCtD
Amoxapine—Dyspepsia—Methotrexate—stomach cancer	0.000106	0.000956	CcSEcCtD
Amoxapine—Olanzapine—ALB—stomach cancer	0.000106	0.0254	CrCbGaD
Amoxapine—Rash—Docetaxel—stomach cancer	0.000106	0.00095	CcSEcCtD
Amoxapine—Hypotension—Epirubicin—stomach cancer	0.000106	0.00095	CcSEcCtD
Amoxapine—Dermatitis—Docetaxel—stomach cancer	0.000106	0.000949	CcSEcCtD
Amoxapine—Confusional state—Doxorubicin—stomach cancer	0.000106	0.000948	CcSEcCtD
Amoxapine—Decreased appetite—Methotrexate—stomach cancer	0.000105	0.000944	CcSEcCtD
Amoxapine—Headache—Docetaxel—stomach cancer	0.000105	0.000944	CcSEcCtD
Amoxapine—Oedema—Doxorubicin—stomach cancer	0.000105	0.00094	CcSEcCtD
Amoxapine—Fatigue—Methotrexate—stomach cancer	0.000104	0.000936	CcSEcCtD
Amoxapine—Vomiting—Capecitabine—stomach cancer	0.000103	0.000927	CcSEcCtD
Amoxapine—Shock—Doxorubicin—stomach cancer	0.000103	0.000925	CcSEcCtD
Amoxapine—Thrombocytopenia—Doxorubicin—stomach cancer	0.000103	0.000921	CcSEcCtD
Amoxapine—Rash—Capecitabine—stomach cancer	0.000102	0.00092	CcSEcCtD
Amoxapine—Insomnia—Epirubicin—stomach cancer	0.000102	0.000919	CcSEcCtD
Amoxapine—Dermatitis—Capecitabine—stomach cancer	0.000102	0.000919	CcSEcCtD
Amoxapine—Tachycardia—Doxorubicin—stomach cancer	0.000102	0.000918	CcSEcCtD
Amoxapine—Headache—Capecitabine—stomach cancer	0.000102	0.000914	CcSEcCtD
Amoxapine—Paraesthesia—Epirubicin—stomach cancer	0.000102	0.000912	CcSEcCtD
Amoxapine—Somnolence—Epirubicin—stomach cancer	0.000101	0.000903	CcSEcCtD
Amoxapine—Anorexia—Doxorubicin—stomach cancer	9.99e-05	0.000896	CcSEcCtD
Amoxapine—Nausea—Docetaxel—stomach cancer	9.97e-05	0.000895	CcSEcCtD
Amoxapine—Feeling abnormal—Methotrexate—stomach cancer	9.97e-05	0.000895	CcSEcCtD
Amoxapine—Dyspepsia—Epirubicin—stomach cancer	9.97e-05	0.000894	CcSEcCtD
Amoxapine—Gastrointestinal pain—Methotrexate—stomach cancer	9.89e-05	0.000888	CcSEcCtD
Amoxapine—Decreased appetite—Epirubicin—stomach cancer	9.84e-05	0.000883	CcSEcCtD
Amoxapine—Hypotension—Doxorubicin—stomach cancer	9.79e-05	0.000879	CcSEcCtD
Amoxapine—Fatigue—Epirubicin—stomach cancer	9.76e-05	0.000876	CcSEcCtD
Amoxapine—Constipation—Epirubicin—stomach cancer	9.68e-05	0.000869	CcSEcCtD
Amoxapine—Nausea—Capecitabine—stomach cancer	9.65e-05	0.000866	CcSEcCtD
Amoxapine—Urticaria—Methotrexate—stomach cancer	9.61e-05	0.000863	CcSEcCtD
Amoxapine—Abdominal pain—Methotrexate—stomach cancer	9.56e-05	0.000858	CcSEcCtD
Amoxapine—Body temperature increased—Methotrexate—stomach cancer	9.56e-05	0.000858	CcSEcCtD
Amoxapine—Insomnia—Doxorubicin—stomach cancer	9.48e-05	0.00085	CcSEcCtD
Amoxapine—Paraesthesia—Doxorubicin—stomach cancer	9.41e-05	0.000844	CcSEcCtD
Amoxapine—Feeling abnormal—Epirubicin—stomach cancer	9.33e-05	0.000837	CcSEcCtD
Amoxapine—Somnolence—Doxorubicin—stomach cancer	9.31e-05	0.000836	CcSEcCtD
Amoxapine—Gastrointestinal pain—Epirubicin—stomach cancer	9.26e-05	0.000831	CcSEcCtD
Amoxapine—Dyspepsia—Doxorubicin—stomach cancer	9.22e-05	0.000828	CcSEcCtD
Amoxapine—Decreased appetite—Doxorubicin—stomach cancer	9.11e-05	0.000817	CcSEcCtD
Amoxapine—Fatigue—Doxorubicin—stomach cancer	9.03e-05	0.000811	CcSEcCtD
Amoxapine—Urticaria—Epirubicin—stomach cancer	8.99e-05	0.000807	CcSEcCtD
Amoxapine—Constipation—Doxorubicin—stomach cancer	8.96e-05	0.000804	CcSEcCtD
Amoxapine—Body temperature increased—Epirubicin—stomach cancer	8.95e-05	0.000803	CcSEcCtD
Amoxapine—Abdominal pain—Epirubicin—stomach cancer	8.95e-05	0.000803	CcSEcCtD
Amoxapine—Asthenia—Methotrexate—stomach cancer	8.68e-05	0.000779	CcSEcCtD
Amoxapine—Feeling abnormal—Doxorubicin—stomach cancer	8.63e-05	0.000775	CcSEcCtD
Amoxapine—Gastrointestinal pain—Doxorubicin—stomach cancer	8.57e-05	0.000769	CcSEcCtD
Amoxapine—Pruritus—Methotrexate—stomach cancer	8.56e-05	0.000768	CcSEcCtD
Amoxapine—Urticaria—Doxorubicin—stomach cancer	8.32e-05	0.000747	CcSEcCtD
Amoxapine—Abdominal pain—Doxorubicin—stomach cancer	8.28e-05	0.000743	CcSEcCtD
Amoxapine—Body temperature increased—Doxorubicin—stomach cancer	8.28e-05	0.000743	CcSEcCtD
Amoxapine—Diarrhoea—Methotrexate—stomach cancer	8.28e-05	0.000743	CcSEcCtD
Amoxapine—Asthenia—Epirubicin—stomach cancer	8.12e-05	0.000729	CcSEcCtD
Amoxapine—Pruritus—Epirubicin—stomach cancer	8.01e-05	0.000719	CcSEcCtD
Amoxapine—Dizziness—Methotrexate—stomach cancer	8e-05	0.000718	CcSEcCtD
Amoxapine—Diarrhoea—Epirubicin—stomach cancer	7.75e-05	0.000695	CcSEcCtD
Amoxapine—Vomiting—Methotrexate—stomach cancer	7.69e-05	0.00069	CcSEcCtD
Amoxapine—Rash—Methotrexate—stomach cancer	7.63e-05	0.000685	CcSEcCtD
Amoxapine—Dermatitis—Methotrexate—stomach cancer	7.62e-05	0.000684	CcSEcCtD
Amoxapine—Headache—Methotrexate—stomach cancer	7.58e-05	0.00068	CcSEcCtD
Amoxapine—Asthenia—Doxorubicin—stomach cancer	7.52e-05	0.000675	CcSEcCtD
Amoxapine—Dizziness—Epirubicin—stomach cancer	7.49e-05	0.000672	CcSEcCtD
Amoxapine—Pruritus—Doxorubicin—stomach cancer	7.41e-05	0.000665	CcSEcCtD
Amoxapine—Vomiting—Epirubicin—stomach cancer	7.2e-05	0.000646	CcSEcCtD
Amoxapine—Nausea—Methotrexate—stomach cancer	7.19e-05	0.000645	CcSEcCtD
Amoxapine—Diarrhoea—Doxorubicin—stomach cancer	7.17e-05	0.000643	CcSEcCtD
Amoxapine—Rash—Epirubicin—stomach cancer	7.14e-05	0.000641	CcSEcCtD
Amoxapine—Dermatitis—Epirubicin—stomach cancer	7.13e-05	0.00064	CcSEcCtD
Amoxapine—Headache—Epirubicin—stomach cancer	7.09e-05	0.000637	CcSEcCtD
Amoxapine—Dizziness—Doxorubicin—stomach cancer	6.93e-05	0.000622	CcSEcCtD
Amoxapine—Nausea—Epirubicin—stomach cancer	6.73e-05	0.000604	CcSEcCtD
Amoxapine—Vomiting—Doxorubicin—stomach cancer	6.66e-05	0.000598	CcSEcCtD
Amoxapine—Rash—Doxorubicin—stomach cancer	6.61e-05	0.000593	CcSEcCtD
Amoxapine—Dermatitis—Doxorubicin—stomach cancer	6.6e-05	0.000592	CcSEcCtD
Amoxapine—Headache—Doxorubicin—stomach cancer	6.56e-05	0.000589	CcSEcCtD
Amoxapine—Nausea—Doxorubicin—stomach cancer	6.22e-05	0.000558	CcSEcCtD
Amoxapine—Diazepam—ALB—stomach cancer	5.63e-05	0.0134	CrCbGaD
Amoxapine—HTR7—Signaling Pathways—EGFR—stomach cancer	3.28e-06	3.04e-05	CbGpPWpGaD
Amoxapine—HTR2A—Signaling Pathways—RHOA—stomach cancer	3.27e-06	3.04e-05	CbGpPWpGaD
Amoxapine—HRH1—Signaling Pathways—RHOA—stomach cancer	3.26e-06	3.03e-05	CbGpPWpGaD
Amoxapine—HTR1B—Signaling Pathways—MYC—stomach cancer	3.26e-06	3.03e-05	CbGpPWpGaD
Amoxapine—CHRM1—Signaling Pathways—RHOA—stomach cancer	3.25e-06	3.02e-05	CbGpPWpGaD
Amoxapine—HTR1A—Signaling Pathways—CDKN1B—stomach cancer	3.25e-06	3.01e-05	CbGpPWpGaD
Amoxapine—HTR2A—Signaling Pathways—NOS3—stomach cancer	3.24e-06	3.01e-05	CbGpPWpGaD
Amoxapine—ADRA2A—Signaling by GPCR—MAPK1—stomach cancer	3.23e-06	3e-05	CbGpPWpGaD
Amoxapine—ADRA2A—Signaling by GPCR—EGFR—stomach cancer	3.23e-06	3e-05	CbGpPWpGaD
Amoxapine—HRH1—Signaling Pathways—NOS3—stomach cancer	3.23e-06	3e-05	CbGpPWpGaD
Amoxapine—HTR2C—Signaling Pathways—CDKN1B—stomach cancer	3.23e-06	3e-05	CbGpPWpGaD
Amoxapine—ADRA2A—Metabolism—PTGS2—stomach cancer	3.22e-06	2.99e-05	CbGpPWpGaD
Amoxapine—CHRM1—Signaling Pathways—NOS3—stomach cancer	3.22e-06	2.99e-05	CbGpPWpGaD
Amoxapine—DRD4—Signaling Pathways—MYC—stomach cancer	3.21e-06	2.98e-05	CbGpPWpGaD
Amoxapine—ADRA1A—Signaling Pathways—RHOA—stomach cancer	3.2e-06	2.97e-05	CbGpPWpGaD
Amoxapine—HTR1B—Signaling Pathways—MAPK1—stomach cancer	3.19e-06	2.96e-05	CbGpPWpGaD
Amoxapine—HTR1B—Signaling Pathways—EGFR—stomach cancer	3.19e-06	2.96e-05	CbGpPWpGaD
Amoxapine—ADRA1A—Signaling Pathways—NOS3—stomach cancer	3.17e-06	2.94e-05	CbGpPWpGaD
Amoxapine—HTR1A—Signaling by GPCR—IL6—stomach cancer	3.16e-06	2.93e-05	CbGpPWpGaD
Amoxapine—HTR2B—Signaling Pathways—MAPK3—stomach cancer	3.15e-06	2.92e-05	CbGpPWpGaD
Amoxapine—HTR2C—Signaling by GPCR—IL6—stomach cancer	3.14e-06	2.92e-05	CbGpPWpGaD
Amoxapine—DRD1—Signaling Pathways—VEGFA—stomach cancer	3.14e-06	2.91e-05	CbGpPWpGaD
Amoxapine—DRD4—Signaling Pathways—MAPK1—stomach cancer	3.14e-06	2.91e-05	CbGpPWpGaD
Amoxapine—DRD4—Signaling Pathways—EGFR—stomach cancer	3.14e-06	2.91e-05	CbGpPWpGaD
Amoxapine—DRD2—Signaling by GPCR—PIK3CA—stomach cancer	3.13e-06	2.91e-05	CbGpPWpGaD
Amoxapine—DRD1—Signaling Pathways—STAT3—stomach cancer	3.11e-06	2.89e-05	CbGpPWpGaD
Amoxapine—HTR6—Signaling Pathways—KRAS—stomach cancer	3.1e-06	2.88e-05	CbGpPWpGaD
Amoxapine—DRD3—Signaling Pathways—VEGFA—stomach cancer	3.1e-06	2.88e-05	CbGpPWpGaD
Amoxapine—HTR7—Signaling Pathways—KRAS—stomach cancer	3.1e-06	2.87e-05	CbGpPWpGaD
Amoxapine—HTR1A—Signaling Pathways—CCND1—stomach cancer	3.1e-06	2.87e-05	CbGpPWpGaD
Amoxapine—HTR1A—Signaling Pathways—JUN—stomach cancer	3.09e-06	2.87e-05	CbGpPWpGaD
Amoxapine—ADRA2A—GPCR downstream signaling—PIK3CA—stomach cancer	3.09e-06	2.87e-05	CbGpPWpGaD
Amoxapine—ADRA2A—Signaling Pathways—SERPINE1—stomach cancer	3.08e-06	2.86e-05	CbGpPWpGaD
Amoxapine—HTR2A—Signaling by GPCR—PIK3CA—stomach cancer	3.08e-06	2.86e-05	CbGpPWpGaD
Amoxapine—HTR2C—Signaling Pathways—CCND1—stomach cancer	3.08e-06	2.86e-05	CbGpPWpGaD
Amoxapine—DRD2—Signaling Pathways—ERBB2—stomach cancer	3.08e-06	2.86e-05	CbGpPWpGaD
Amoxapine—HRH1—Signaling by GPCR—PIK3CA—stomach cancer	3.08e-06	2.86e-05	CbGpPWpGaD
Amoxapine—HTR2C—Signaling Pathways—JUN—stomach cancer	3.07e-06	2.85e-05	CbGpPWpGaD
Amoxapine—DRD3—Signaling Pathways—STAT3—stomach cancer	3.07e-06	2.85e-05	CbGpPWpGaD
Amoxapine—CHRM1—Signaling by GPCR—PIK3CA—stomach cancer	3.07e-06	2.85e-05	CbGpPWpGaD
Amoxapine—HTR2B—Signaling Pathways—MYC—stomach cancer	3.06e-06	2.84e-05	CbGpPWpGaD
Amoxapine—ADRA2A—Signaling by GPCR—KRAS—stomach cancer	3.05e-06	2.83e-05	CbGpPWpGaD
Amoxapine—CYP2D6—Metabolism—CAV1—stomach cancer	3.04e-06	2.82e-05	CbGpPWpGaD
Amoxapine—CYP2D6—Metabolism—APOA1—stomach cancer	3.03e-06	2.81e-05	CbGpPWpGaD
Amoxapine—HTR2A—Signaling Pathways—ERBB2—stomach cancer	3.03e-06	2.81e-05	CbGpPWpGaD
Amoxapine—HRH1—Signaling Pathways—ERBB2—stomach cancer	3.02e-06	2.8e-05	CbGpPWpGaD
Amoxapine—ADRA1A—Signaling by GPCR—PIK3CA—stomach cancer	3.02e-06	2.8e-05	CbGpPWpGaD
Amoxapine—HTR1B—Signaling Pathways—KRAS—stomach cancer	3.01e-06	2.8e-05	CbGpPWpGaD
Amoxapine—CHRM1—Signaling Pathways—ERBB2—stomach cancer	3.01e-06	2.8e-05	CbGpPWpGaD
Amoxapine—HTR1A—Signaling Pathways—MMP9—stomach cancer	3.01e-06	2.79e-05	CbGpPWpGaD
Amoxapine—HTR2B—Signaling Pathways—MAPK1—stomach cancer	3e-06	2.78e-05	CbGpPWpGaD
Amoxapine—HTR2B—Signaling Pathways—EGFR—stomach cancer	3e-06	2.78e-05	CbGpPWpGaD
Amoxapine—HTR1A—Signaling Pathways—CDKN1A—stomach cancer	3e-06	2.78e-05	CbGpPWpGaD
Amoxapine—HTR2C—Signaling Pathways—MMP9—stomach cancer	2.99e-06	2.78e-05	CbGpPWpGaD
Amoxapine—HTR2C—Signaling Pathways—CDKN1A—stomach cancer	2.98e-06	2.77e-05	CbGpPWpGaD
Amoxapine—ADRA2A—Signaling Pathways—RHOA—stomach cancer	2.98e-06	2.76e-05	CbGpPWpGaD
Amoxapine—DRD1—Signaling Pathways—MAPK3—stomach cancer	2.97e-06	2.76e-05	CbGpPWpGaD
Amoxapine—ADRA1A—Signaling Pathways—ERBB2—stomach cancer	2.96e-06	2.75e-05	CbGpPWpGaD
Amoxapine—DRD4—Signaling Pathways—KRAS—stomach cancer	2.96e-06	2.75e-05	CbGpPWpGaD
Amoxapine—ADRA2A—Signaling Pathways—NOS3—stomach cancer	2.95e-06	2.73e-05	CbGpPWpGaD
Amoxapine—DRD3—Signaling Pathways—MAPK3—stomach cancer	2.93e-06	2.72e-05	CbGpPWpGaD
Amoxapine—HTR1A—Signaling Pathways—MAPK8—stomach cancer	2.92e-06	2.71e-05	CbGpPWpGaD
Amoxapine—DRD2—Signaling Pathways—CXCL8—stomach cancer	2.92e-06	2.71e-05	CbGpPWpGaD
Amoxapine—HTR2C—Signaling Pathways—MAPK8—stomach cancer	2.91e-06	2.7e-05	CbGpPWpGaD
Amoxapine—DRD2—Signaling by GPCR—HRAS—stomach cancer	2.9e-06	2.69e-05	CbGpPWpGaD
Amoxapine—DRD1—Signaling Pathways—MYC—stomach cancer	2.89e-06	2.68e-05	CbGpPWpGaD
Amoxapine—HTR2A—Signaling Pathways—CXCL8—stomach cancer	2.87e-06	2.67e-05	CbGpPWpGaD
Amoxapine—HRH1—Signaling Pathways—CXCL8—stomach cancer	2.87e-06	2.66e-05	CbGpPWpGaD
Amoxapine—CHRM1—Signaling Pathways—CXCL8—stomach cancer	2.86e-06	2.65e-05	CbGpPWpGaD
Amoxapine—HTR2A—Signaling by GPCR—HRAS—stomach cancer	2.85e-06	2.65e-05	CbGpPWpGaD
Amoxapine—DRD3—Signaling Pathways—MYC—stomach cancer	2.85e-06	2.65e-05	CbGpPWpGaD
Amoxapine—DRD2—Signaling Pathways—CDKN1B—stomach cancer	2.85e-06	2.65e-05	CbGpPWpGaD
Amoxapine—HTR6—Signaling Pathways—PIK3CA—stomach cancer	2.85e-06	2.64e-05	CbGpPWpGaD
Amoxapine—HRH1—Signaling by GPCR—HRAS—stomach cancer	2.85e-06	2.64e-05	CbGpPWpGaD
Amoxapine—HTR7—Signaling Pathways—PIK3CA—stomach cancer	2.85e-06	2.64e-05	CbGpPWpGaD
Amoxapine—CHRM1—Signaling by GPCR—HRAS—stomach cancer	2.84e-06	2.63e-05	CbGpPWpGaD
Amoxapine—HTR2B—Signaling Pathways—KRAS—stomach cancer	2.83e-06	2.63e-05	CbGpPWpGaD
Amoxapine—DRD1—Signaling Pathways—MAPK1—stomach cancer	2.83e-06	2.62e-05	CbGpPWpGaD
Amoxapine—DRD1—Signaling Pathways—EGFR—stomach cancer	2.83e-06	2.62e-05	CbGpPWpGaD
Amoxapine—ADRA1A—Signaling Pathways—CXCL8—stomach cancer	2.81e-06	2.61e-05	CbGpPWpGaD
Amoxapine—ADRA2A—Signaling by GPCR—PIK3CA—stomach cancer	2.81e-06	2.6e-05	CbGpPWpGaD
Amoxapine—HTR2A—Signaling Pathways—CDKN1B—stomach cancer	2.8e-06	2.6e-05	CbGpPWpGaD
Amoxapine—HRH1—Signaling Pathways—CDKN1B—stomach cancer	2.8e-06	2.6e-05	CbGpPWpGaD
Amoxapine—ADRA1A—Signaling by GPCR—HRAS—stomach cancer	2.79e-06	2.59e-05	CbGpPWpGaD
Amoxapine—CHRM1—Signaling Pathways—CDKN1B—stomach cancer	2.79e-06	2.59e-05	CbGpPWpGaD
Amoxapine—DRD3—Signaling Pathways—MAPK1—stomach cancer	2.79e-06	2.59e-05	CbGpPWpGaD
Amoxapine—DRD3—Signaling Pathways—EGFR—stomach cancer	2.79e-06	2.59e-05	CbGpPWpGaD
Amoxapine—DRD2—Signaling by GPCR—IL6—stomach cancer	2.77e-06	2.58e-05	CbGpPWpGaD
Amoxapine—HTR1B—Signaling Pathways—PIK3CA—stomach cancer	2.77e-06	2.57e-05	CbGpPWpGaD
Amoxapine—HTR6—Signaling Pathways—TP53—stomach cancer	2.76e-06	2.56e-05	CbGpPWpGaD
Amoxapine—ADRA2A—Signaling Pathways—ERBB2—stomach cancer	2.75e-06	2.56e-05	CbGpPWpGaD
Amoxapine—HTR7—Signaling Pathways—TP53—stomach cancer	2.75e-06	2.56e-05	CbGpPWpGaD
Amoxapine—ADRA1A—Signaling Pathways—CDKN1B—stomach cancer	2.75e-06	2.55e-05	CbGpPWpGaD
Amoxapine—HTR2A—Signaling by GPCR—IL6—stomach cancer	2.73e-06	2.53e-05	CbGpPWpGaD
Amoxapine—HRH1—Signaling by GPCR—IL6—stomach cancer	2.72e-06	2.53e-05	CbGpPWpGaD
Amoxapine—DRD4—Signaling Pathways—PIK3CA—stomach cancer	2.72e-06	2.53e-05	CbGpPWpGaD
Amoxapine—DRD2—Signaling Pathways—CCND1—stomach cancer	2.72e-06	2.52e-05	CbGpPWpGaD
Amoxapine—CHRM1—Signaling by GPCR—IL6—stomach cancer	2.72e-06	2.52e-05	CbGpPWpGaD
Amoxapine—DRD2—Signaling Pathways—JUN—stomach cancer	2.71e-06	2.52e-05	CbGpPWpGaD
Amoxapine—HTR1A—Signaling Pathways—VEGFA—stomach cancer	2.7e-06	2.51e-05	CbGpPWpGaD
Amoxapine—HTR2C—Signaling Pathways—VEGFA—stomach cancer	2.69e-06	2.49e-05	CbGpPWpGaD
Amoxapine—HTR1B—Signaling Pathways—TP53—stomach cancer	2.68e-06	2.49e-05	CbGpPWpGaD
Amoxapine—HTR2A—Signaling Pathways—CCND1—stomach cancer	2.68e-06	2.48e-05	CbGpPWpGaD
Amoxapine—ADRA1A—Signaling by GPCR—IL6—stomach cancer	2.67e-06	2.48e-05	CbGpPWpGaD
Amoxapine—HTR1A—Signaling Pathways—STAT3—stomach cancer	2.67e-06	2.48e-05	CbGpPWpGaD
Amoxapine—HTR2A—Signaling Pathways—JUN—stomach cancer	2.67e-06	2.48e-05	CbGpPWpGaD
Amoxapine—HRH1—Signaling Pathways—CCND1—stomach cancer	2.67e-06	2.48e-05	CbGpPWpGaD
Amoxapine—DRD1—Signaling Pathways—KRAS—stomach cancer	2.67e-06	2.48e-05	CbGpPWpGaD
Amoxapine—CYP2D6—Metabolism—PPARG—stomach cancer	2.67e-06	2.48e-05	CbGpPWpGaD
Amoxapine—HRH1—Signaling Pathways—JUN—stomach cancer	2.66e-06	2.47e-05	CbGpPWpGaD
Amoxapine—CHRM1—Signaling Pathways—CCND1—stomach cancer	2.66e-06	2.47e-05	CbGpPWpGaD
Amoxapine—HTR2C—Signaling Pathways—STAT3—stomach cancer	2.66e-06	2.47e-05	CbGpPWpGaD
Amoxapine—CHRM1—Signaling Pathways—JUN—stomach cancer	2.66e-06	2.46e-05	CbGpPWpGaD
Amoxapine—DRD2—Signaling Pathways—MMP9—stomach cancer	2.64e-06	2.45e-05	CbGpPWpGaD
Amoxapine—HTR6—Signaling Pathways—HRAS—stomach cancer	2.64e-06	2.45e-05	CbGpPWpGaD
Amoxapine—DRD4—Signaling Pathways—TP53—stomach cancer	2.63e-06	2.45e-05	CbGpPWpGaD
Amoxapine—DRD3—Signaling Pathways—KRAS—stomach cancer	2.63e-06	2.44e-05	CbGpPWpGaD
Amoxapine—HTR7—Signaling Pathways—HRAS—stomach cancer	2.63e-06	2.44e-05	CbGpPWpGaD
Amoxapine—DRD2—Signaling Pathways—CDKN1A—stomach cancer	2.63e-06	2.44e-05	CbGpPWpGaD
Amoxapine—ADRA1A—Signaling Pathways—CCND1—stomach cancer	2.62e-06	2.43e-05	CbGpPWpGaD
Amoxapine—ADRA1A—Signaling Pathways—JUN—stomach cancer	2.61e-06	2.43e-05	CbGpPWpGaD
Amoxapine—ADRA2A—Signaling Pathways—CXCL8—stomach cancer	2.61e-06	2.43e-05	CbGpPWpGaD
Amoxapine—HTR2B—Signaling Pathways—PIK3CA—stomach cancer	2.6e-06	2.41e-05	CbGpPWpGaD
Amoxapine—HTR2A—Signaling Pathways—MMP9—stomach cancer	2.6e-06	2.41e-05	CbGpPWpGaD
Amoxapine—ADRA2A—Signaling by GPCR—HRAS—stomach cancer	2.6e-06	2.41e-05	CbGpPWpGaD
Amoxapine—HRH1—Signaling Pathways—MMP9—stomach cancer	2.59e-06	2.41e-05	CbGpPWpGaD
Amoxapine—HTR2A—Signaling Pathways—CDKN1A—stomach cancer	2.59e-06	2.4e-05	CbGpPWpGaD
Amoxapine—CHRM1—Signaling Pathways—MMP9—stomach cancer	2.58e-06	2.4e-05	CbGpPWpGaD
Amoxapine—HRH1—Signaling Pathways—CDKN1A—stomach cancer	2.58e-06	2.4e-05	CbGpPWpGaD
Amoxapine—CHRM1—Signaling Pathways—CDKN1A—stomach cancer	2.57e-06	2.39e-05	CbGpPWpGaD
Amoxapine—DRD2—Signaling Pathways—MAPK8—stomach cancer	2.57e-06	2.38e-05	CbGpPWpGaD
Amoxapine—HTR1B—Signaling Pathways—HRAS—stomach cancer	2.56e-06	2.38e-05	CbGpPWpGaD
Amoxapine—HTR1A—Signaling Pathways—MAPK3—stomach cancer	2.55e-06	2.37e-05	CbGpPWpGaD
Amoxapine—ADRA2A—Signaling Pathways—CDKN1B—stomach cancer	2.55e-06	2.37e-05	CbGpPWpGaD
Amoxapine—ADRA1A—Signaling Pathways—MMP9—stomach cancer	2.54e-06	2.36e-05	CbGpPWpGaD
Amoxapine—HTR2C—Signaling Pathways—MAPK3—stomach cancer	2.54e-06	2.36e-05	CbGpPWpGaD
Amoxapine—ADRA1A—Signaling Pathways—CDKN1A—stomach cancer	2.53e-06	2.35e-05	CbGpPWpGaD
Amoxapine—HTR2A—Signaling Pathways—MAPK8—stomach cancer	2.53e-06	2.34e-05	CbGpPWpGaD
Amoxapine—HTR6—Signaling Pathways—IL6—stomach cancer	2.52e-06	2.34e-05	CbGpPWpGaD
Amoxapine—HRH1—Signaling Pathways—MAPK8—stomach cancer	2.52e-06	2.34e-05	CbGpPWpGaD
Amoxapine—DRD4—Signaling Pathways—HRAS—stomach cancer	2.52e-06	2.34e-05	CbGpPWpGaD
Amoxapine—HTR7—Signaling Pathways—IL6—stomach cancer	2.52e-06	2.34e-05	CbGpPWpGaD
Amoxapine—HTR2B—Signaling Pathways—TP53—stomach cancer	2.52e-06	2.33e-05	CbGpPWpGaD
Amoxapine—CHRM1—Signaling Pathways—MAPK8—stomach cancer	2.51e-06	2.33e-05	CbGpPWpGaD
Amoxapine—ADRA2A—Signaling by GPCR—IL6—stomach cancer	2.48e-06	2.31e-05	CbGpPWpGaD
Amoxapine—HTR1A—Signaling Pathways—MYC—stomach cancer	2.48e-06	2.31e-05	CbGpPWpGaD
Amoxapine—ADRA1A—Signaling Pathways—MAPK8—stomach cancer	2.47e-06	2.3e-05	CbGpPWpGaD
Amoxapine—HTR2C—Signaling Pathways—MYC—stomach cancer	2.47e-06	2.29e-05	CbGpPWpGaD
Amoxapine—DRD1—Signaling Pathways—PIK3CA—stomach cancer	2.45e-06	2.28e-05	CbGpPWpGaD
Amoxapine—HTR1B—Signaling Pathways—IL6—stomach cancer	2.45e-06	2.28e-05	CbGpPWpGaD
Amoxapine—ADRA2A—Signaling Pathways—CCND1—stomach cancer	2.43e-06	2.26e-05	CbGpPWpGaD
Amoxapine—HTR1A—Signaling Pathways—MAPK1—stomach cancer	2.43e-06	2.26e-05	CbGpPWpGaD
Amoxapine—HTR1A—Signaling Pathways—EGFR—stomach cancer	2.43e-06	2.26e-05	CbGpPWpGaD
Amoxapine—ADRA2A—Signaling Pathways—JUN—stomach cancer	2.43e-06	2.25e-05	CbGpPWpGaD
Amoxapine—DRD3—Signaling Pathways—PIK3CA—stomach cancer	2.42e-06	2.25e-05	CbGpPWpGaD
Amoxapine—HTR2C—Signaling Pathways—MAPK1—stomach cancer	2.42e-06	2.24e-05	CbGpPWpGaD
Amoxapine—HTR2C—Signaling Pathways—EGFR—stomach cancer	2.42e-06	2.24e-05	CbGpPWpGaD
Amoxapine—DRD4—Signaling Pathways—IL6—stomach cancer	2.41e-06	2.24e-05	CbGpPWpGaD
Amoxapine—HTR2B—Signaling Pathways—HRAS—stomach cancer	2.41e-06	2.23e-05	CbGpPWpGaD
Amoxapine—CYP2D6—Metabolism—ALB—stomach cancer	2.4e-06	2.23e-05	CbGpPWpGaD
Amoxapine—DRD1—Signaling Pathways—TP53—stomach cancer	2.37e-06	2.2e-05	CbGpPWpGaD
Amoxapine—DRD2—Signaling Pathways—VEGFA—stomach cancer	2.37e-06	2.2e-05	CbGpPWpGaD
Amoxapine—ADRA2A—Signaling Pathways—MMP9—stomach cancer	2.36e-06	2.19e-05	CbGpPWpGaD
Amoxapine—ADRA2A—Signaling Pathways—CDKN1A—stomach cancer	2.35e-06	2.19e-05	CbGpPWpGaD
Amoxapine—DRD2—Signaling Pathways—STAT3—stomach cancer	2.35e-06	2.18e-05	CbGpPWpGaD
Amoxapine—DRD3—Signaling Pathways—TP53—stomach cancer	2.34e-06	2.17e-05	CbGpPWpGaD
Amoxapine—HTR2A—Signaling Pathways—VEGFA—stomach cancer	2.33e-06	2.16e-05	CbGpPWpGaD
Amoxapine—HRH1—Signaling Pathways—VEGFA—stomach cancer	2.33e-06	2.16e-05	CbGpPWpGaD
Amoxapine—CHRM1—Signaling Pathways—VEGFA—stomach cancer	2.32e-06	2.15e-05	CbGpPWpGaD
Amoxapine—HTR2A—Signaling Pathways—STAT3—stomach cancer	2.31e-06	2.14e-05	CbGpPWpGaD
Amoxapine—HRH1—Signaling Pathways—STAT3—stomach cancer	2.3e-06	2.14e-05	CbGpPWpGaD
Amoxapine—HTR2B—Signaling Pathways—IL6—stomach cancer	2.3e-06	2.14e-05	CbGpPWpGaD
Amoxapine—ADRA2A—Signaling Pathways—MAPK8—stomach cancer	2.3e-06	2.13e-05	CbGpPWpGaD
Amoxapine—CHRM1—Signaling Pathways—STAT3—stomach cancer	2.3e-06	2.13e-05	CbGpPWpGaD
Amoxapine—CYP2D6—Metabolism—NOS3—stomach cancer	2.3e-06	2.13e-05	CbGpPWpGaD
Amoxapine—HTR1A—Signaling Pathways—KRAS—stomach cancer	2.29e-06	2.13e-05	CbGpPWpGaD
Amoxapine—ADRA1A—Signaling Pathways—VEGFA—stomach cancer	2.28e-06	2.12e-05	CbGpPWpGaD
Amoxapine—HTR2C—Signaling Pathways—KRAS—stomach cancer	2.28e-06	2.12e-05	CbGpPWpGaD
Amoxapine—DRD1—Signaling Pathways—HRAS—stomach cancer	2.27e-06	2.11e-05	CbGpPWpGaD
Amoxapine—ADRA1A—Signaling Pathways—STAT3—stomach cancer	2.26e-06	2.1e-05	CbGpPWpGaD
Amoxapine—DRD2—Signaling Pathways—MAPK3—stomach cancer	2.24e-06	2.08e-05	CbGpPWpGaD
Amoxapine—DRD3—Signaling Pathways—HRAS—stomach cancer	2.24e-06	2.08e-05	CbGpPWpGaD
Amoxapine—HTR2A—Signaling Pathways—MAPK3—stomach cancer	2.21e-06	2.05e-05	CbGpPWpGaD
Amoxapine—HRH1—Signaling Pathways—MAPK3—stomach cancer	2.2e-06	2.04e-05	CbGpPWpGaD
Amoxapine—CHRM1—Signaling Pathways—MAPK3—stomach cancer	2.19e-06	2.04e-05	CbGpPWpGaD
Amoxapine—DRD2—Signaling Pathways—MYC—stomach cancer	2.18e-06	2.02e-05	CbGpPWpGaD
Amoxapine—DRD1—Signaling Pathways—IL6—stomach cancer	2.17e-06	2.02e-05	CbGpPWpGaD
Amoxapine—ADRA1A—Signaling Pathways—MAPK3—stomach cancer	2.16e-06	2.01e-05	CbGpPWpGaD
Amoxapine—HTR2A—Signaling Pathways—MYC—stomach cancer	2.15e-06	1.99e-05	CbGpPWpGaD
Amoxapine—DRD3—Signaling Pathways—IL6—stomach cancer	2.14e-06	1.99e-05	CbGpPWpGaD
Amoxapine—HRH1—Signaling Pathways—MYC—stomach cancer	2.14e-06	1.99e-05	CbGpPWpGaD
Amoxapine—CHRM1—Signaling Pathways—MYC—stomach cancer	2.13e-06	1.98e-05	CbGpPWpGaD
Amoxapine—DRD2—Signaling Pathways—MAPK1—stomach cancer	2.13e-06	1.98e-05	CbGpPWpGaD
Amoxapine—DRD2—Signaling Pathways—EGFR—stomach cancer	2.13e-06	1.98e-05	CbGpPWpGaD
Amoxapine—ADRA2A—Signaling Pathways—VEGFA—stomach cancer	2.12e-06	1.97e-05	CbGpPWpGaD
Amoxapine—HTR1A—Signaling Pathways—PIK3CA—stomach cancer	2.11e-06	1.96e-05	CbGpPWpGaD
Amoxapine—ADRA1A—Signaling Pathways—MYC—stomach cancer	2.1e-06	1.95e-05	CbGpPWpGaD
Amoxapine—ADRA2A—Signaling Pathways—STAT3—stomach cancer	2.1e-06	1.95e-05	CbGpPWpGaD
Amoxapine—HTR2A—Signaling Pathways—MAPK1—stomach cancer	2.1e-06	1.95e-05	CbGpPWpGaD
Amoxapine—CYP2D6—Metabolism—PTGS2—stomach cancer	2.1e-06	1.95e-05	CbGpPWpGaD
Amoxapine—HTR2A—Signaling Pathways—EGFR—stomach cancer	2.1e-06	1.95e-05	CbGpPWpGaD
Amoxapine—HTR2C—Signaling Pathways—PIK3CA—stomach cancer	2.1e-06	1.95e-05	CbGpPWpGaD
Amoxapine—HRH1—Signaling Pathways—MAPK1—stomach cancer	2.09e-06	1.94e-05	CbGpPWpGaD
Amoxapine—HRH1—Signaling Pathways—EGFR—stomach cancer	2.09e-06	1.94e-05	CbGpPWpGaD
Amoxapine—CHRM1—Signaling Pathways—MAPK1—stomach cancer	2.09e-06	1.94e-05	CbGpPWpGaD
Amoxapine—CHRM1—Signaling Pathways—EGFR—stomach cancer	2.09e-06	1.94e-05	CbGpPWpGaD
Amoxapine—ADRA1A—Signaling Pathways—MAPK1—stomach cancer	2.06e-06	1.91e-05	CbGpPWpGaD
Amoxapine—ADRA1A—Signaling Pathways—EGFR—stomach cancer	2.06e-06	1.91e-05	CbGpPWpGaD
Amoxapine—HTR1A—Signaling Pathways—TP53—stomach cancer	2.04e-06	1.89e-05	CbGpPWpGaD
Amoxapine—HTR2C—Signaling Pathways—TP53—stomach cancer	2.03e-06	1.88e-05	CbGpPWpGaD
Amoxapine—DRD2—Signaling Pathways—KRAS—stomach cancer	2.01e-06	1.87e-05	CbGpPWpGaD
Amoxapine—ADRA2A—Signaling Pathways—MAPK3—stomach cancer	2.01e-06	1.86e-05	CbGpPWpGaD
Amoxapine—HTR2A—Signaling Pathways—KRAS—stomach cancer	1.98e-06	1.84e-05	CbGpPWpGaD
Amoxapine—ADRA2A—Metabolism—PIK3CA—stomach cancer	1.98e-06	1.84e-05	CbGpPWpGaD
Amoxapine—HRH1—Signaling Pathways—KRAS—stomach cancer	1.98e-06	1.84e-05	CbGpPWpGaD
Amoxapine—CHRM1—Signaling Pathways—KRAS—stomach cancer	1.97e-06	1.83e-05	CbGpPWpGaD
Amoxapine—ADRA2A—Signaling Pathways—MYC—stomach cancer	1.95e-06	1.81e-05	CbGpPWpGaD
Amoxapine—HTR1A—Signaling Pathways—HRAS—stomach cancer	1.95e-06	1.81e-05	CbGpPWpGaD
Amoxapine—ADRA1A—Signaling Pathways—KRAS—stomach cancer	1.94e-06	1.8e-05	CbGpPWpGaD
Amoxapine—HTR2C—Signaling Pathways—HRAS—stomach cancer	1.94e-06	1.8e-05	CbGpPWpGaD
Amoxapine—ADRA2A—Signaling Pathways—MAPK1—stomach cancer	1.91e-06	1.77e-05	CbGpPWpGaD
Amoxapine—ADRA2A—Signaling Pathways—EGFR—stomach cancer	1.91e-06	1.77e-05	CbGpPWpGaD
Amoxapine—HTR1A—Signaling Pathways—IL6—stomach cancer	1.87e-06	1.73e-05	CbGpPWpGaD
Amoxapine—HTR2C—Signaling Pathways—IL6—stomach cancer	1.86e-06	1.72e-05	CbGpPWpGaD
Amoxapine—DRD2—Signaling Pathways—PIK3CA—stomach cancer	1.85e-06	1.72e-05	CbGpPWpGaD
Amoxapine—HTR2A—Signaling Pathways—PIK3CA—stomach cancer	1.82e-06	1.69e-05	CbGpPWpGaD
Amoxapine—HRH1—Signaling Pathways—PIK3CA—stomach cancer	1.82e-06	1.69e-05	CbGpPWpGaD
Amoxapine—CHRM1—Signaling Pathways—PIK3CA—stomach cancer	1.81e-06	1.68e-05	CbGpPWpGaD
Amoxapine—ADRA2A—Signaling Pathways—KRAS—stomach cancer	1.8e-06	1.67e-05	CbGpPWpGaD
Amoxapine—DRD2—Signaling Pathways—TP53—stomach cancer	1.79e-06	1.66e-05	CbGpPWpGaD
Amoxapine—ADRA1A—Signaling Pathways—PIK3CA—stomach cancer	1.78e-06	1.66e-05	CbGpPWpGaD
Amoxapine—HTR2A—Signaling Pathways—TP53—stomach cancer	1.76e-06	1.64e-05	CbGpPWpGaD
Amoxapine—HRH1—Signaling Pathways—TP53—stomach cancer	1.76e-06	1.63e-05	CbGpPWpGaD
Amoxapine—CHRM1—Signaling Pathways—TP53—stomach cancer	1.75e-06	1.63e-05	CbGpPWpGaD
Amoxapine—ADRA1A—Signaling Pathways—TP53—stomach cancer	1.73e-06	1.6e-05	CbGpPWpGaD
Amoxapine—DRD2—Signaling Pathways—HRAS—stomach cancer	1.71e-06	1.59e-05	CbGpPWpGaD
Amoxapine—HTR2A—Signaling Pathways—HRAS—stomach cancer	1.69e-06	1.56e-05	CbGpPWpGaD
Amoxapine—HRH1—Signaling Pathways—HRAS—stomach cancer	1.68e-06	1.56e-05	CbGpPWpGaD
Amoxapine—CHRM1—Signaling Pathways—HRAS—stomach cancer	1.68e-06	1.56e-05	CbGpPWpGaD
Amoxapine—ADRA2A—Signaling Pathways—PIK3CA—stomach cancer	1.66e-06	1.54e-05	CbGpPWpGaD
Amoxapine—ADRA1A—Signaling Pathways—HRAS—stomach cancer	1.65e-06	1.53e-05	CbGpPWpGaD
Amoxapine—DRD2—Signaling Pathways—IL6—stomach cancer	1.64e-06	1.52e-05	CbGpPWpGaD
Amoxapine—HTR2A—Signaling Pathways—IL6—stomach cancer	1.61e-06	1.5e-05	CbGpPWpGaD
Amoxapine—HRH1—Signaling Pathways—IL6—stomach cancer	1.61e-06	1.49e-05	CbGpPWpGaD
Amoxapine—CHRM1—Signaling Pathways—IL6—stomach cancer	1.6e-06	1.49e-05	CbGpPWpGaD
Amoxapine—ADRA2A—Signaling Pathways—TP53—stomach cancer	1.6e-06	1.49e-05	CbGpPWpGaD
Amoxapine—ADRA1A—Signaling Pathways—IL6—stomach cancer	1.58e-06	1.47e-05	CbGpPWpGaD
Amoxapine—ADRA2A—Signaling Pathways—HRAS—stomach cancer	1.53e-06	1.42e-05	CbGpPWpGaD
Amoxapine—ADRA2A—Signaling Pathways—IL6—stomach cancer	1.47e-06	1.36e-05	CbGpPWpGaD
Amoxapine—CYP2D6—Metabolism—PIK3CA—stomach cancer	1.29e-06	1.2e-05	CbGpPWpGaD
